Complications of therapeutic plasma exchange: Experience with 4857 treatments

被引:139
作者
Basic-Jukic, N [1 ]
Kes, P [1 ]
Glavas-Boras, S [1 ]
Brunetta, B [1 ]
Bubic-Filipi, L [1 ]
Puretic, Z [1 ]
机构
[1] Univ Zagreb, Ctr Hosp, Dept Dialysis, HR-1000 Zagreb, Croatia
关键词
adverse reactions; allergic reactions; clotting; complications; hypotension; plasma exchange;
D O I
10.1111/j.1744-9987.2005.00319.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Plasma exchange (PE) is a technique of extracorporeal blood purification which removes large molecular weight substances from plasma. The Department of Dialysis, Zagreb University Hospital Center's database, which includes data on 509 patients, or 4857 PE treatments, was retrospectively analyzed to test the safety of PE. A total of 231 adverse reactions were recorded (4.75% of treatments). The most common complications were paresthesias (2.7 %), hematoma at the puncture site (2.4 %), clotting (1.7%), mild to moderate allergic reactions (urticaria; 1.6 %) and bleeding (0.06%). True anaphylactoid reactions were recorded in five procedures. The incidence of severe, potentially life-threatening adverse reactions was 0.12%. The prophylactic use of calcium and potassium was responsible for a low incidence of electrolyte disturbances. There was no lethal outcome associated with PE. When carried out by experienced staff, PE is a relatively safe procedure. The use of fresh frozen plasma is associated with a higher rate of adverse reactions. Key Words: Adverse reactions, Allergic reactions, Clotting, Complications, Hypotension, Plasma exchange.
引用
收藏
页码:391 / 395
页数:5
相关论文
共 28 条
[1]  
AUFEUVRE JP, 1982, PLASMAPHERESIS IMMUN, P65
[2]   INDICATIONS OF PLASMAPHERESIS AND SELECTION OF DIFFERENT SUBSTITUTION SOLUTIONS [J].
BAMBAUER, R ;
JUTZLER, GA ;
ALBRECHT, D ;
KELLER, HE ;
KOHLER, M .
BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS, 1989, 17 (01) :9-26
[3]  
Basic-Jukic N., 2004, Acta Medica Croatica, V58, P63
[4]  
Borberg H, 1980, THERAPEUTIC PLASMA E, P191
[5]  
Brecher ME, 1997, J CLIN APHERESIS, V12, P146, DOI 10.1002/(SICI)1098-1101(1997)12:3<146::AID-JCA8>3.0.CO
[6]  
2-A
[7]  
FABRE M, 1980, PLASMA EXCHANGE, P143
[8]  
HUESTIS DW, 1983, LANCET, V1, P1043
[9]  
Isbister JP, 1990, THERAPEUTIC HEMAPHER, P10
[10]  
KAPLAN AA, 1990, ASAIO T, V36, P597